Biotech startup MobiDrop is China’s first multi-platform molecular diagnostics company. Founded by Pei Hao in 2018, the company’s products include MobiNova, a cost-effective single-cell multiomic platform that can profile a large number of single cells per run. Headquartered in Jiaxing, China with its Center for Global Innovation and Business Development in Boston, USA, MobiDrop raised Series A+ funding of US$14.8 million in 2022.